N-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and icu patients: a meta-analysis

Pradelli L, Mayer K, Muscaritoli M, Heller AR. – Crit Care 2012; 16(5): R184

A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in Italy

Dal Negro RW, Tognella S, Pradelli L. – J Asthma 2012; 49(8): 843-8

Perceval sutureless valves in isolated and concomitant avr procedures: an economic model shows overall decrease of costs for isolated or combined operations

Pradelli L, Zaniolo O. – Farmeconomia. Health economics and therapeutic pathways 2012; 13(4): 159-174

Effectiveness and cost-effectiveness of supplemental glutamine dipeptide in total parenteral nutrition therapy for critically ill patients: a discrete event simulation model based on italian data

Pradelli L, Iannazzo S, Zaniolo O, Muscaritoli M, Eandi M. – International Journal of Technology Assessment in Health Care 2012; 28(1): 22–28

A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries

Iannazzo S, Carsi M, Chiroli S. – Appl Health Econ Health Policy 2012; 10(2): 127-38

Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (copd) in Italy

Zaniolo O, Iannazzo S, Pradelli L, Miravitlles M. – Eur J Health Econ 2012; 13(1): 71-80